Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Balestro

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Journal of Clinical Medicine|March 27, 2019
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung PathologyElisabetta Cocconcelli, Elisabetta Balestro, Davide Biondini, et al.
Lung|February 25, 2025
Prevalence and Predictors of Response to Antifibrotics in Long-Term Survivors with Idiopathic Pulmonary FibrosisElisabetta Cocconcelli, Nicol Bernardinello, Paolo Cameli, et al.
Virchows Archiv : an International Journal of Pathology|July 19, 2024
The role of pathologists in the diagnosis of occupational lung diseases: an expert opinion of the European Society of Pathology Pulmonary Pathology Working GroupFiorella Calabrese, M Angeles Montero-Fernandez, Izidor Kern, et al.
Respiration; International Review of Thoracic Diseases|April 26, 2021
Low-Blood Lymphocyte Number and Lymphocyte Decline as Key Factors in COPD Outcomes: A Longitudinal Cohort StudyUmberto Semenzato, Davide Biondini, Erica Bazzan, et al.
Frontiers in Immunology|May 14, 2023
Macrophages-derived Factor XIII links coagulation to inflammation in COPDErica Bazzan, Alvise Casara, Claudia Maria Radu, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 27, 2021
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?Meena Kalluri, Fabrizio Luppi, Ada Vancheri, et al.
Respiration; International Review of Thoracic Diseases|April 28, 2026
AN ITALIAN NETWORK FOR THE MANAGEMENT OF SEVERE COVID-19 DISEASE IN RESPIRATORY INTERMEDIATE CARE UNITS (RICU): THE PNEUMO-COV-VEN-ITMartina Turrin, Andrea Francavilla, Elisabetta Balestro, et al.
ERJ Open Research|October 26, 2019
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide surveyCatharina C Moor, Marlies S Wijsenbeek, Elisabetta Balestro, et al.
Respiration; International Review of Thoracic Diseases|March 28, 2018
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary FibrosisSergio Harari, Antonella Caminati, Venerino Poletti, et al.
RMD Open|August 4, 2023
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohortElisabetta Zanatta, Elisabetta Cocconcelli, Gioele Castelli, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|March 27, 2019
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung PathologyElisabetta Cocconcelli, Elisabetta Balestro, Davide Biondini, et al.
Lung|February 25, 2025
Prevalence and Predictors of Response to Antifibrotics in Long-Term Survivors with Idiopathic Pulmonary FibrosisElisabetta Cocconcelli, Nicol Bernardinello, Paolo Cameli, et al.
Virchows Archiv : an International Journal of Pathology|July 19, 2024
The role of pathologists in the diagnosis of occupational lung diseases: an expert opinion of the European Society of Pathology Pulmonary Pathology Working GroupFiorella Calabrese, M Angeles Montero-Fernandez, Izidor Kern, et al.
Respiration; International Review of Thoracic Diseases|April 26, 2021
Low-Blood Lymphocyte Number and Lymphocyte Decline as Key Factors in COPD Outcomes: A Longitudinal Cohort StudyUmberto Semenzato, Davide Biondini, Erica Bazzan, et al.
Frontiers in Immunology|May 14, 2023
Macrophages-derived Factor XIII links coagulation to inflammation in COPDErica Bazzan, Alvise Casara, Claudia Maria Radu, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 27, 2021
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?Meena Kalluri, Fabrizio Luppi, Ada Vancheri, et al.
Respiration; International Review of Thoracic Diseases|April 28, 2026
AN ITALIAN NETWORK FOR THE MANAGEMENT OF SEVERE COVID-19 DISEASE IN RESPIRATORY INTERMEDIATE CARE UNITS (RICU): THE PNEUMO-COV-VEN-ITMartina Turrin, Andrea Francavilla, Elisabetta Balestro, et al.
ERJ Open Research|October 26, 2019
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide surveyCatharina C Moor, Marlies S Wijsenbeek, Elisabetta Balestro, et al.
Respiration; International Review of Thoracic Diseases|March 28, 2018
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary FibrosisSergio Harari, Antonella Caminati, Venerino Poletti, et al.
RMD Open|August 4, 2023
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohortElisabetta Zanatta, Elisabetta Cocconcelli, Gioele Castelli, et al.
Pageof 10